CTD // Fund
BioMap
AI-based precision medicine supporting tool for drug discovery
← Fund directoryBioMap is a corporate investor (Cheminformatics,) founded in 2020 and headquartered in Beijing, China. AI-based precision medicine supporting tool for drug discovery. The company has developed software that uses AI technology for research and development. It has features for multi-omic data analysis, drug designing, and more. Practice areas include Life Sciences and HealthTech. As a corporate investor, the firm makes strategic investments that align with its parent company's business objectives, seeking both financial returns and strategic value through ecosystem partnerships.
- Stage
- Not disclosed
- HQ
- Beijing, china
- Founded
- 2020
- Website
- https://biomap.com
- LinkedIn
- https://linkedin.com/company/biomap2023
Corporate InvestorArtificial Intelligence
📊 Ballpark pre-money for pipeline deals — estimate equity value before you diligence a round.
⚠️ Common pitch mistakes we see →
Preparing to pitch BioMap?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →